Macquarie Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.89M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $28K | Sell |
|
|||||
|
2022
Q4 | $1.62M | Sell |
|
|||||
|
2022
Q3 | $54.8M | Buy |
|
|||||
|
2022
Q2 | $5.47M | Buy |
|
|||||
|
2022
Q1 | $123 | Hold |
|
|||||
|
2021
Q4 | $149K | Sell |
|
|||||
|
2021
Q3 | $110M | Sell |
|
|||||
|
2021
Q2 | $188M | Buy |
|
|||||
|
2021
Q1 | $516K | Sell |
|
|||||
|
2020
Q4 | $24.5M | Buy |
|
|||||
|
2020
Q3 | $5.61M | Sell |
|
|||||
|
2020
Q2 | $7.01M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $14K | Buy |
|